Ibuprofen
- Product NDC
- 53746-132
- 11-digit product format
- 537460132
- Labeler code
- 53746
- Product ID
- 53746-132_fc9fc973-31c3-42df-93e7-eeeeb280bcaa
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Ibuprofen
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Amneal Pharmaceuticals of New York LLC
- Application
- ANDA071335
- Marketing category
- ANDA
- Marketing start
- 2009-01-05
- Substance
- IBUPROFEN
- Active strength
- 600 mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Ibuprofen
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| IBUPROFEN | 600 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | WK2XYI10QM |
| Rxcui | 197806 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 53746-132-01 | 2021-03-18 | C162847 | 48780-1 | ba0f9c33-313b-a910-e053-dadaa90a0b85 | IBUPROFEN TABLETS, USP |
| 53746-132-05 | 2021-03-18 | C162847 | 48780-1 | ba0f9c33-313b-a910-e053-dadaa90a0b85 | IBUPROFEN TABLETS, USP |
| 53746-132-30 | 2021-03-18 | C162847 | 48780-1 | ba0f9c33-313b-a910-e053-dadaa90a0b85 | IBUPROFEN TABLETS, USP |
| 53746-132-50 | 2021-03-18 | C162847 | 48780-1 | ba0f9c33-313b-a910-e053-dadaa90a0b85 | IBUPROFEN TABLETS, USP |
| 53746-132-60 | 2021-03-18 | C162847 | 48780-1 | ba0f9c33-313b-a910-e053-dadaa90a0b85 | IBUPROFEN TABLETS, USP |
| 53746-132-90 | 2021-03-18 | C162847 | 48780-1 | ba0f9c33-313b-a910-e053-dadaa90a0b85 | IBUPROFEN TABLETS, USP |
| 53746-132-01 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-313b-a910-e053-dadaa90a0b85 | IBUPROFEN TABLETS, USP |
| 53746-132-05 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-313b-a910-e053-dadaa90a0b85 | IBUPROFEN TABLETS, USP |
| 53746-132-30 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-313b-a910-e053-dadaa90a0b85 | IBUPROFEN TABLETS, USP |
| 53746-132-50 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-313b-a910-e053-dadaa90a0b85 | IBUPROFEN TABLETS, USP |
| 53746-132-60 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-313b-a910-e053-dadaa90a0b85 | IBUPROFEN TABLETS, USP |
| 53746-132-90 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-313b-a910-e053-dadaa90a0b85 | IBUPROFEN TABLETS, USP |
DailyMed Package Descriptions#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 53746-132 | IBUPROFEN TABLET [AMNEAL PHARMACEUTICALS OF NEW YORK LLC] | 14 | Current NDC, Legacy NDC, 6 package rows | 20241222_8df77ead-27eb-4f6f-95a9-f68d3e9cfa71.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 53746-132-01 | 53746013201 | 100 TABLET in 1 BOTTLE (53746-132-01) | 100 tablet | 2009-01-05 | 0000-00-00 | No | No | Current |
| 53746-132-05 | 53746013205 | 500 TABLET in 1 BOTTLE (53746-132-05) | 500 tablet | 2009-01-05 | 0000-00-00 | No | No | Current |
| 53746-132-30 | 53746013230 | 30 TABLET in 1 BOTTLE (53746-132-30) | 30 tablet | 2009-01-05 | 0000-00-00 | No | No | Current |
| 53746-132-50 | 53746013250 | 50 TABLET in 1 BOTTLE (53746-132-50) | 50 tablet | 2009-01-05 | 0000-00-00 | No | No | Current |
| 53746-132-60 | 53746013260 | 60 TABLET in 1 BOTTLE (53746-132-60) | 60 tablet | 2009-01-05 | 0000-00-00 | No | No | Current |
| 53746-132-90 | 53746013290 | 90 TABLET in 1 BOTTLE (53746-132-90) | 90 tablet | 2009-01-05 | 0000-00-00 | No | No | Current |